Yes , not harmful at low doses . Now I believe they increase the dose to arrive at the efficacy level which is right as a starting point for the phase 2 trials . Of course they have to satisfy the TGA and the FDA requirements as phase 2 are planned for the USA and Australia .
SBP
solbec pharmaceuticals limited
Yes , not harmful at low doses . Now I believe they increase the...
Add to My Watchlist
What is My Watchlist?